Safety, not only efficacy still to be proven for controversial new MS treatment
Can J Neurol Sci
.
2011 Sep;38(5):667-8.
doi: 10.1017/s0317167100118578.
Author
Marcelo Kremenchutzky
PMID:
21856565
DOI:
10.1017/s0317167100118578
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Cerebrovascular Disorders / surgery*
Female
Humans
Male
Multiple Sclerosis / etiology*
Stents / adverse effects*
Grants and funding
Canadian Institutes of Health Research/Canada